Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
NAD⁺ & NMN
Video summary

Podcast description: Verdin on metabolism, immunity and aging biology

In this podcast description, Dr. Eric Verdin of the Buck Institute discusses what drives aging, covering metabolism, NAD+, ketone bodies, insulin signaling, inflammation, immune aging, longevity drugs, lifestyle and biomarkers. The video and transcript were not reviewed. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The description says the episode explores what actually drives aging, from metabolism and epigenetics to inflammation and immune aging. [1]

  2. Listed topics include how NAD+, ketone bodies and insulin signaling influence aging and the promise and limitations of drugs like rapamycin and metformin. [1]

  3. The description says exercise, sleep, nutrition and lifestyle still matter most today and mentions hype in longevity science and biomarkers. [1]

The source at a glance

Study type / format
Podcast episode description
Population / context
Not specified; the description names Dr. Eric Verdin as guest and two hosts.
Summary based on
Creator description
Original publication
May 27, 2026

Metabolism, NAD+ and insulin in the described talk

According to the description, the episode asks what actually drives aging. Verdin is said to explain how molecular systems inside cells shape healthspan and longevity. The listed topics include why metabolism is more than energy production and how NAD+, ketone bodies and insulin signaling influence aging. These are topics the description says are discussed; the description gives no results, measurements or effect sizes.

Supporting source [1]

Inflammation, immune aging and longevity drugs in the episode

The description lists chronic inflammation, called inflammaging, and its role in disease and decline, and says the immune system may be one of the central drivers of aging. It also names the promise and limitations of longevity drugs such as rapamycin and metformin. The description does not report doses, trial results or which limitations were discussed, so no benefit or safety conclusion can be drawn from it.

Supporting source [1]

Lifestyle, hype and biomarkers as listed topics

The description says the conversation covers why exercise, sleep, nutrition and lifestyle still matter most today, the problem of Instagram medicine and hype in longevity science, and biomarkers, biological clocks and the future of scientific wellness. It also mentions epigenetic reprogramming and rejuvenation biology as future directions. These are announced topics only; the description contains no findings, and the video and transcript were not reviewed.

Supporting source [1]

How to interpret this

Only the video description was available; the video and transcript were not reviewed. The description announces topics without reporting study designs, data, doses or results, so it supports no conclusions about benefits or safety.

Based on the creator’s description; the full video and transcript were not analyzed.

Source & supporting passages

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    What actually drives aging
  2. Finding 2 ↑

    ketone bodies, and insulin signaling influence aging
  3. Finding 3 ↑

    exercise, sleep, nutrition, and lifestyle still matter

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…